Peritoneal Carcinoma Clinical Trials

33 clinical trials for Peritoneal Carcinoma across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery — RECRUITING · PHASE2
• Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2 — RECRUITING
• Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors — RECRUITING · PHASE1
• A RANDOMIZED PHASE III, TWO-ARM TRIAL OF PACLITAXEL/CARBOPLATIN/MAINTENANCE LETROZOLE VERSUS LETROZOLE MONOTHERAPY IN PATIENTS WITH STAGE II-IV, PRIMARY LOW-GRADE SEROUS CARCINOMA OF THE OVARY OR PERITONEUM — RECRUITING · PHASE3
• Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy — COMPLETED · PHASE2
• A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum — ACTIVE_NOT_RECRUITING · PHASE2
• Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — ACTIVE_NOT_RECRUITING · PHASE3
• Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy — ACTIVE_NOT_RECRUITING · PHASE2
• A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY OF AZENOSERTIB VERSUS INVESTIGATOR’S CHOICE OF CHEMOTHERAPY IN PLATINUM RESISTANT HIGH-GRADE SEROUS OVARIAN, PRIMARY PERITONEAL, OR FALLOPIAN TUBE CANCERS POSITIVE FOR CYCLIN E1 PROTEIN EXPRESSION — NOT_YET_RECRUITING · PHASE3
• A Trial Evaluating TG4050 in Ovarian Carcinoma. — COMPLETED · PHASE1
• Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC — COMPLETED · PHASE1
• NM32-2668 in Adult Patients With Selected Advanced Solid Tumors — TERMINATED · PHASE1
• A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors — TERMINATED · PHASE1
• CAR T Cells in Mesothelin Expressing Cancers — COMPLETED · PHASE1
• SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer — NOT_YET_RECRUITING · PHASE1
• Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers — NOT_YET_RECRUITING
• International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis — NOT_YET_RECRUITING
• Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators — OTHER
• Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer — OTHER · PHASE2
• Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer — COMPLETED · PHASE1
• DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma — WITHDRAWN · PHASE3
• Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma — TERMINATED · PHASE1
• Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer — TERMINATED · PHASE1
• Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy — COMPLETED
• Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer — COMPLETED · PHASE1
• Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer — COMPLETED · PHASE1
• Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia — OTHER · NA
• WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer — TERMINATED · NA
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2) — COMPLETED
• (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma — TERMINATED · PHASE2
• Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer — COMPLETED · PHASE2
• Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer — TERMINATED · PHASE3

Refine this search